James Brett Case

2015–2025 年に発表

80
論文数
19,890
被引用数
51
h 指数
78
i10 指数

被引用数

James Brett Case の年別被引用数2001 年: 被引用 1 件2005 年: 被引用 1 件2015 年: 被引用 1 件2016 年: 被引用 3 件2017 年: 被引用 3 件2018 年: 被引用 6 件2019 年: 被引用 46 件2020 年: 被引用 1,642 件2021 年: 被引用 2,995 件2022 年: 被引用 2,175 件2023 年: 被引用 884 件2024 年: 被引用 1,084 件2025 年: 被引用 386 件2026 年: 被引用 6 件2002〜2004 年は被引用が無いため表示していません2006〜2014 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,856 件、この内訳の 28.9%中国: 引用元論文 1,143 件、この内訳の 11.6%イギリス: 引用元論文 606 件、この内訳の 6.1%ドイツ: 引用元論文 409 件、この内訳の 4.1%インド: 引用元論文 356 件、この内訳の 3.6%フランス: 引用元論文 312 件、この内訳の 3.2%カナダ: 引用元論文 310 件、この内訳の 3.1%イタリア: 引用元論文 303 件、この内訳の 3.1%オーストラリア: 引用元論文 255 件、この内訳の 2.6%日本: 引用元論文 244 件、この内訳の 2.5%スイス: 引用元論文 232 件、この内訳の 2.3%オランダ: 引用元論文 172 件、この内訳の 1.7%
0%28.9%その他 27.2%

分野

  • Medicine81.2%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Immunology and Microbiology5%
  • Computer Science1.6%
  • Agricultural and Biological Sciences0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • その他2.5%

トピック

  • SARS-CoV-2 and COVID-19 Research24.6%
  • COVID-19 Clinical Research Studies14%
  • SARS-CoV-2 detection and testing3.8%
  • Animal Virus Infections Studies3.7%
  • Viral gastroenteritis research and epidemiology3.6%
  • Long-Term Effects of COVID-193.5%
  • その他46.8%

共著者

全論文

検索で開く
  1. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 被引用: 2,160

  2. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 被引用: 890

  3. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

    著者: , , , , , , , , , , , , , , - Science 2020 被引用: 734

  4. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy R. Henry, Karl Čiuoderis, Kelsey R. Florek, Mit Patel, Abby Odle, Lok-Yin Roy Wong, Allen Bateman, Zhongde Wang, Venkata Viswanadh Edara, Zhenlu Chong, John Franks, Trushar Jeevan, Thomas Fabrizio, Jennifer DeBeauchamp, Lisa Kercher, Patrick Seiler, Ana S. Gonzalez‐Reiche, Emilia Mia Sordillo, Lauren A. Chang, Harm van Bakel, Viviana Simon, Bremy Alburquerque, Hala Alshammary, Angela A. Amoako, Sadaf Aslam, Radhika Banu, Christian Cognigni, Marlene Espinoza‐Moraga, Keith Farrugia, Adriana van de Guchte, Zain Khalil, Manon Laporte, Ignacio Mena, Alberto Paniz‐Mondolfi, J. Polanco, Aria Rooker, Levy A. Sominsky, Daniel C. Douek, Nancy J. Sullivan, Larissa B. Thackray, Hiroshi Ueki, Seiya Yamayoshi, Masaki Imai, Stanley Perlman, Richard J. Webby, Robert A. Seder, Mehul S. Suthar, Adolfo García‐Sastre, Michael Schotsaert, Tadaki Suzuki, Adrianus C. M. Boon, Michael Diamond, Yoshihiro Kawaoka - Nature 2022 被引用: 700

  5. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Diamond - Cell 2020 被引用: 635

  6. Potently neutralizing and protective human antibodies against SARS-CoV-2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicole L. Kallewaard, Broc T. McCune, Shamus P. Keeler, Michael J. Holtzman, Dan H. Barouch, Lisa E. Gralinski, Ralph S. Baric, Larissa B. Thackray, Michael Diamond, Robert H. Carnahan, James E. Crowe - Nature 2020 被引用: 1,201

  7. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William T. Hu, F. Eun‐Hyung Lee, Igñacio Sanz - Nature Immunology 2020 被引用: 795

  8. Neutralization, effector function and immune imprinting of Omicron variants

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julia Noack, Alex Chen, Florian A. Lempp, Joel Quispe, Lauriane Kergoat, Florence Larrous, Elisabetta Cameroni, Bradley Whitener, Olivier Giannini, Pietro E. Cippà, Alessandro Ceschi, Paolo Ferrari, Alessandra Franzetti-Pellanda, Maira Biggiogero, Christian Garzoni, Stephanie Zappi, Luca Bernasconi, Minjeong Kim, Laura E. Rosen, Gretja Schnell, Nadine Czudnochowski, Fabio Benigni, Nicholas Franko, Jennifer K. Logue, Courtney Yoshiyama, Cameron Stewart, Helen Y. Chu, Hervé Bourhy, Michael Schmid, Lisa A. Purcell, Gyorgy Snell, Antonio Lanzavecchia, Michael Diamond, Davide Corti, David Veesler - Nature 2023 被引用: 181

  9. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pei‐Yong Shi, Michael Diamond - Nature Medicine 2021 被引用: 1,015

  10. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

    著者: , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2017 被引用: 1,634

  11. The antigenic anatomy of SARS-CoV-2 receptor binding domain

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert H. Levin, Tao Dong, Andrew J. Pollard, Julian C. Knight, Paul Klenerman, Nigel Temperton, David R. Hall, Mark A. Williams, Neil G. Paterson, F.K.R. Bertram, C. Alistair Siebert, Daniel K. Clare, Andrew Howe, Julika Radecke, Yun Song, Alain Townsend, Kuan-Ying A. Huang, Elizabeth E. Fry, Juthathip Mongkolsapaya, Michael Diamond, Jingshan Ren, David I. Stuart, Gavin Screaton - Cell 2021 被引用: 440

  12. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

    著者: , , , , , , , , , , , , , , , , - mBio 2018 被引用: 1,514

  13. LDLRAD3 is a receptor for Venezuelan equine encephalitis virus

    著者: , , , , , , , , , , , , , - Nature 2020 被引用: 167

  14. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katja Culap, Fabio Benigni, Rana Abdelnabi, Caroline S. Foo, Michael Schmid, Elisabetta Cameroni, Agostino Riva, Arianna Gabrieli, Massimo Galli, Matteo Samuele Pizzuto, Johan Neyts, Michael Diamond, Herbert W. Virgin, Gyorgy Snell, Davide Corti, Katja Fink, David Veesler - Science 2020 被引用: 630

  15. Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesse D. Bloom, James E. Crowe - Nature Microbiology 2021 被引用: 330

  16. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ousman Jobe, Vincent Dussupt, Sebastian Molnar, Ursula Tran, Chandrika B. Kannadka, Sandrine Soman, Caitlin Kuklis, Michelle Zemil, Htet Khanh, Weimin Wu, Matthew Cole, Debra K. Duso, Larry Kummer, Tricia J. Lang, Shania E. Muncil, Jeffrey R. Currier, Shelly J. Krebs, Victoria R. Polonis, Saravanan Rajan, Patrick M. McTamney, Mark T. Esser, William W. Reiley, Morgane Rolland, Natalia de Val, Michael Diamond, Gregory D. Gromowski, Gary R. Matyas, Mangala Rao, Nelson L. Michael, Kayvon Modjarrad - Cell Reports 2021 被引用: 186

  17. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

    著者: , , , , , , , , , , , , , , , , , , , - Cell 2021 被引用: 392

  18. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manoj S. Nair, Vincent Dussupt, Sharon P. Daye, Xiankun Zeng, Erica K. Barkei, Hilary Staples, Kendra J. Alfson, Ricardo Carrion, Shelly J. Krebs, Dominic Paquin‐Proulx, Nicos Karasavva, Victoria R. Polonis, Linda L. Jagodzinski, Mihret F. Amare, Sandhya Vasan, Paul T. Scott, Yaoxing Huang, David D. Ho, Natalia de Val, Michael Diamond, Mark G. Lewis, Mangala Rao, Gary R. Matyas, Gregory D. Gromowski, Sheila A. Peel, Nelson L. Michael, Diane L. Bolton, Kayvon Modjarrad - Science Translational Medicine 2022 被引用: 145

  19. Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines

    著者: , , , , , , , , , , , , , , , , , , , - Nature 2024 被引用: 81

  20. Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds

    著者: , , , , , , , , , , , , , , , , - Nature Communications 2024 被引用: 79

  21. Growth, detection, quantification, and inactivation of SARS-CoV-2

    著者: , , , , - Virology 2020 被引用: 295

  22. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 154

  23. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , - Cell 2020 被引用: 579

  24. Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natasha I. Edman, George Ueda, Cameron M. Chow, Max Johnson, Amin Addetia, Mary-Jane Navarro, Nuttada Panpradist, Michael Gale, Benjamin Freedman, Jesse D. Bloom, Hannele Ruohola‐Baker, Sean P. J. Whelan, Lance Stewart, Michael Diamond, David Veesler, Michael C. Jewett, David Baker - Science Translational Medicine 2022 被引用: 118